2. AMH - A BIOMARKER THAT PREDICTS SUCCESSFUL SPERM RETRIEVAL IN PATIENTS WITH NON-OBSTRUCTIVE AZOOSPERMIA: OVERVIEW OF CURRENT EVIDENCE IN HUMANS
Main Article Content
Abstract
Introduction: Non-obstructive azoospermia (NOA) is considered as the most severe form of male infertility. The rate of sperm retrieval from NOA men after mTESE surgery is still only ranging from 30% to 60%. In case sperm is not found, which can have unexpected repercussions for to the patient such as: pain, testicular damage, endocrine impairment, and costly expenses... Therefore, predicting the sperm retrieval rate (SSR) is crucial for NOA patients to consider whether or not to get surgery.
Objective: To find out the relationship between AMH hormone and sperm retrieval rate of NOA patients undergoing surgical testicular sperm extraction.
Method: PUBMED, EMBASE, CENTRAL, and Web of Science were utilized for overview knowledge. A host of studies were conducted to compare AMH biomarkers in NOA men undergoing the surgical testicular sperm extraction.
Results: Serum AMH concentration is a potential biomarker to predict sperm retrieval rate for a subgroup of patients with idiopathic NOA or non-mosaic Klinefelter syndrome. However, The power of evidence is not strong enough due to small sample sizes and most studies being retrospective. In contrast, seminal AMH is not currently used as an effective biomarker predicting positive sperm retrieval rate.
Conclusion: The available evidence is insufficient to help clinicians make adequate decisions support, and more prospective, large sample size, and multicenter trials are urgently needed.
Article Details
Keywords
AMH, mTESE, non-obstructive azoospermia (NOA), sperm retrieval rate (SSR).
References
manual for the examination and processing of
human semen Sixth Edition, 2021.
[2] A Agarwal, A Mulgund, A Hamada et al., A
unique view on male infertility around the globe,
Reproductive Biology and Endocrinology, vol.
13, no. 1, p. 37, Dec. 2015, doi: 10.1186/s12958-
015-0032-1.
[3] S Friedler, A Raziel, D Strassburger et al.,
Testicular sperm retrieval by percutaneous
fine needle sperm aspiration compared with
testicular sperm extraction by open biopsy in
men with non-obstructive azoospermia, Human
Reproduction, vol. 12, no. 7, pp. 1488–1493, Jul.
1997, doi: 10.1093/humrep/12.7.1488.
[4] R Ron-El, S Strauss, S Friedler et al., Serial
sonography and colour flow Doppler imaging
following testicular and epididymal sperm
extraction, Human Reproduction, vol. 13, no.
12, pp. 3390–3393, Dec. 1998, doi: 10.1093/
humrep/13.12.3390.
[5] PN Schlegel, LM Su, Physiological consequences
of testicular sperm extraction, Human
Reproduction, vol. 12, no. 8, pp. 1688–1692,
Aug. 1997, doi: 10.1093/humrep/12.8.1688.
[6] Hao L, Li-Ping C, Juncheng Y et al.,
Predictive value of FSH, testicular volume, and
histopathological findings for the sperm retrieval
rate of microdissection TESE in non-obstructive
azoospermia: a meta-analysis, Asian J Androl,
vol. 20, no. 1, p. 30, 2018, doi: 10.4103/aja.
aja_5_17.
[7] RA Rey et al., Evaluation of Gonadal Function
in 107 Intersex Patients by Means of Serum
Antimüllerian Hormone Measurement, J Clin
Endocrinol Metab, vol. 84, no. 2, pp. 627–631,14
Feb. 1999, doi: 10.1210/jcem.84.2.5507.
[8] MM LEE, PK DONAHOE, Mullerian Inhibiting
Substance: A Gonadal Hormone with Multiple
Functions, Endocr Rev, vol. 14, no. 2, pp. 152–
164, Apr. 1993, doi: 10.1210/edrv-14-2-152.
[9] E Matuszczak, A Hermanowicz, M Komarowska
et al., Serum AMH in Physiology and Pathology
of Male Gonads, Int J Endocrinol, vol. 2013, pp.
1–6, 2013, doi: 10.1155/2013/128907.
[10] NY Edelsztein, RP Grinspon, HF Schteingart
et al., Anti-Müllerian hormone as a marker of
steroid and gonadotropin action in the testis of
children and adolescents with disorders of the
gonadal axis, Int J Pediatr Endocrinol, vol. 2016,
no. 1, p. 20, Dec. 2016, doi: 10.1186/s13633-
016-0038-2.
[11] M Alfano et al., Anti-Mullerian Hormone-to
Testosterone Ratio is Predictive of Positive
Sperm Retrieval in Men with Idiopathic Non-
Obstructive Azoospermia, Sci Rep, vol. 7, no. 1,
p. 17638, Dec. 2017, doi: 10.1038/s41598-017-
17420-z.
[12] DG Goulis et al., Serum anti-Müllerian hormone
levels differentiate control from subfertile
men but not men with different causes of
subfertility, Gynecological Endocrinology,
vol. 24, no. 3, pp. 158–160, Jan. 2008, doi:
10.1080/09513590701672314.
[13] F Tüttelmann, N Dykstra, APN Themmen et al.,
Anti-Müllerian hormone in men with normal
and reduced sperm concentration and men with
maldescended testes, Fertil Steril, vol. 91, no.
5, pp. 1812–1819, May 2009, doi: 10.1016/j.
fertnstert.2008.02.118.
[14] MH Hassan, HM Ibrahim, MA ElTaieb, 25-
Hydroxy cholecalciferol, antiMüllerian hormone,
and thyroid profiles among infertile men, The
Aging Male, vol.23, no. 5, pp. 513–519, Dec. 2020, doi:
10.1080/13685538.2018.1538338.
[15] DG Goulis et al., Serum inhibin B and antiMüllerian
hormone are not superior to folliclestimulating
hormone as predictors of the presence
of sperm in testicular fine-needle aspiration in
men with azoospermia, Fertil Steril, vol. 91, no.
4, pp. 1279–1284, Apr. 2009, doi: 10.1016/j.
fertnstert.2008.01.010.
[16] M Isikoglu, K Ozgur, S Oehninger et al., Serum
anti-Müllerian hormone levels do not predict the
efficiency of testicular sperm retrieval in men with
non-obstructive azoospermia, Gynecological
Endocrinology, vol. 22, no. 5, pp. 256–260, Jan.
2006, doi: 10.1080/09513590600624366.
[17] T Ishikawa, K Yamaguchi, Y Takaya et al.,
Predictors for sperm retrieval in microdissection
sperm extraction for non-obstructive
azoospermia, Fertil Steril, vol. 104, no. 3, p. e294,
Sep. 2015, doi: 10.1016/j.fertnstert.2015.07.920.
[18] H Benderradji et al., Contribution of serum
anti-Müllerian hormone in the management
of azoospermia and the prediction of testicular
sperm retrieval outcomes: a study of 155 adult
men, Basic Clin Androl, vol. 31, no. 1, p. 15,
Dec. 2021, doi: 10.1186/s12610-021-00133-9.
[19] N Josso et al., Anti-Müllerian hormone in early
human development, Early Hum Dev, vol. 33,
no. 2, pp. 91–99, Jun. 1993, doi: 10.1016/0378-
3782(93)90204-8.
[20] JM Andersen, H Herning, O Witczak et al.,
AntiMüllerian hormone in seminal plasma and serum:
association with sperm count and sperm motility,
Human Reproduction, vol. 31, no. 8, pp. 1662–
1667, Aug. 2016, doi: 10.1093/humrep/dew121.
[21] R Kucera, Z Ulcova-Gallova, J Windrichova
et al., Anti-Müllerian hormone in serum and
seminal plasma in comparison with other male
fertility parameters, Syst Biol Reprod Med,
vol. 62, no. 3, pp. 223–226, May 2016, doi:
10.3109/19396368.2016.1161864.
[22] A La Marca et al., Anti-Mullerian hormone
(AMH) as a predictive marker in assisted
reproductive technology (ART), Hum Reprod
Update, vol. 16, no. 2, pp. 113–130, Mar. 2010,
doi: 10.1093/humupd/dmp036.
[23] P Fénichel, R Rey, S Poggioli et al., AntiMüllerian
hormone as a seminal marker
for spermatogenesis in non-obstructive
azoospermia, Human Reproduction, vol. 14,
no. 8, pp. 2020–2024, Aug. 1999, doi: 10.1093/
humrep/14.8.2020.15
[24] S Soudabeh et al., Comparing Seminal Plasma
Biomarkers between Normospermic and
Azoospermic Men., J Reprod Infertil, vol. 11,
no. 1, pp. 39–46, Apr. 2010.
[25] T Mostafa et al., Seminal plasma anti-M?llerian
hormone level correlates with semen parameters
but does not predict success of testicular sperm
extraction (TESE), Asian J Androl, vol. 9, no.
2, pp. 265–270, Mar. 2007, doi: 10.1111/j.1745-
7262.2007.00252.x.
[26] E Duvilla, H Lejeune, B Trombert-Paviot et al.,
Significance of inhibin B and anti-Müllerian
hormone in seminal plasma: a preliminary study,
Fertil Steril, vol. 89, no. 2, pp. 444–448, Feb.
2008, doi: 10.1016/j.fertnstert.2007.03.032.
[27] V Mitchell et al., Seminal plasma levels of
anti-Müllerian hormone and inhibin B are not
predictive of testicular sperm retrieval in non-
obstructive azoospermia: a study of 139 men,
Fertil Steril, vol. 94, no. 6, pp. 2147–2150, Nov.
2010, doi: 10.1016/j.fertnstert.2009.11.046.